European Society for Medical Oncology (ESMO) Congress 2022
https://corcept.com/wp-content/uploads/COR-logo.svg00jeremiah@devisedesigns.comhttps://corcept.com/wp-content/uploads/COR-logo.svgjeremiah@devisedesigns.com2023-02-11 00:00:002024-03-14 21:25:21Phase 1 Results of Exicorilant + Enzalutamide in Patients with Castration-Resistant Prostate Cancer
